Lexie B2 Plus vs Signia Pure C&G IX

The Lexie B2 Plus is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.4/5, placing it in the top 9% of OTC devices tested in our lab. At $899, this behind-the-ear style device delivers strong performance in several key areas while showing some limitations worth considering. In our testing, the Lexie B2 Plus excels in speech clarity for quiet environments, scoring a strong 4.3/5—significantly above the OTC category average by 1.49 points. Own-voice comfort is a particular standout at 4.8/5, well above the category average by 2.29 points, meaning wearers are unlikely to experience the hollow or booming quality of their own voice that can make some hearing aids uncomfortable. Speech in noise performance scores 2.1/5, which is above the OTC category average by 0.58 points but remains mixed in absolute terms—typical for this device class. Music streaming scores 2.6/5, similarly above average by 0.68 points while remaining modest overall. Feedback handling at 2.8/5 falls below the category average by 1.74 points, which may require attention during phone calls or when wearing hats. The Lexie B2 Plus is a solid choice for users prioritizing speech clarity in quieter settings and natural own-voice comfort. It features rechargeable batteries and streaming compatibility with both iPhone and Android devices. This two-time Expert's Choice Award winner (2023, 2024) competes against devices like the higher-scoring Sony CRE-E10 in its price range, but offers a compelling balance of comfort and core speech performance.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.